Citadel Advisors’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.73M | Buy |
+145,900
| New | +$2.78M | ﹤0.01% | 5450 |
|
|
2025
Q4 | – | Sell |
-37,600
| Closed | -$1.01M | – | 14015 |
|
|
2025
Q3 | $1.01M | Sell |
37,600
-37,400
| -50% | -$892K | ﹤0.01% | 7524 |
|
|
2025
Q2 | $1.26M | Sell |
75,000
-27,100
| -27% | -$478K | ﹤0.01% | 6596 |
|
|
2025
Q1 | $1.8M | Buy |
102,100
+61,900
| +154% | +$1.24M | ﹤0.01% | 5729 |
|
|
2024
Q4 | $976K | Sell |
40,200
-108,700
| -73% | -$3.1M | ﹤0.01% | 7075 |
|
|
2024
Q3 | $5.53M | Buy |
148,900
+120,600
| +426% | +$4.5M | ﹤0.01% | 3784 |
|
|
2024
Q2 | $1.35M | Sell |
28,300
-84,600
| -75% | -$3.71M | ﹤0.01% | 6046 |
|
|
2024
Q1 | $4.32M | Buy |
112,900
+27,700
| +33% | +$901K | ﹤0.01% | 4169 |
|
|
2023
Q4 | $2.66M | Buy |
85,200
+44,900
| +111% | +$1.61M | ﹤0.01% | 4864 |
|
|
2023
Q3 | $1.62M | Sell |
40,300
-9,700
| -19% | -$454K | ﹤0.01% | 5603 |
|
|
2023
Q2 | $2.63M | Buy |
50,000
+5,100
| +11% | +$311K | ﹤0.01% | 4683 |
|
|
2023
Q1 | $2.87M | Sell |
44,900
-3,800
| -8% | -$248K | ﹤0.01% | 4711 |
|
|
2022
Q4 | $2.36M | Sell |
48,700
-180,400
| -79% | -$11.3M | ﹤0.01% | 5162 |
|
|
2022
Q3 | $16.2M | Buy |
229,100
+151,600
| +196% | +$13M | ﹤0.01% | 2125 |
|
|
2022
Q2 | $5.5M | Buy |
77,500
+16,700
| +27% | +$1.08M | ﹤0.01% | 3617 |
|
|
2022
Q1 | $4.86M | Sell |
60,800
-7,800
| -11% | -$581K | ﹤0.01% | 4227 |
|
|
2021
Q4 | $6.26M | Sell |
68,600
-5,800
| -8% | -$622K | ﹤0.01% | 3900 |
|
|
2021
Q3 | $9.56M | Buy |
74,400
+7,700
| +12% | +$1.08M | ﹤0.01% | 3163 |
|
|
2021
Q2 | $10.2M | Sell |
66,700
-6,000
| -8% | -$790K | ﹤0.01% | 3036 |
|
|
2021
Q1 | $7.66M | Sell |
72,700
-6,000
| -8% | -$601K | ﹤0.01% | 3409 |
|
|
2020
Q4 | $6.24M | Buy |
78,700
+12,900
| +20% | +$944K | ﹤0.01% | 3310 |
|
|
2020
Q3 | $3.72M | Sell |
65,800
-9,200
| -12% | -$495K | ﹤0.01% | 3598 |
|
|
2020
Q2 | $4.62M | Buy |
75,000
+9,700
| +15% | +$396K | ﹤0.01% | 3199 |
|
|
2020
Q1 | $2.11M | Buy |
65,300
+35,100
| +116% | +$1.18M | ﹤0.01% | 4062 |
|
|
2019
Q4 | $1.06M | Buy |
30,200
+17,100
| +131% | +$564K | ﹤0.01% | 5474 |
|
|
2019
Q3 | $338K | Sell |
13,100
-13,900
| -51% | -$422K | ﹤0.01% | 7386 |
|
|
2019
Q2 | $793K | Hold |
27,000
| – | – | ﹤0.01% | 6085 |
|
|
2019
Q1 | $923K | Sell |
27,000
-19,900
| -42% | -$704K | ﹤0.01% | 5730 |
|
|
2018
Q4 | $1.5M | Sell |
46,900
-8,000
| -15% | -$312K | ﹤0.01% | 4634 |
|
|
2018
Q3 | $2.63M | Buy |
54,900
+34,500
| +169% | +$1.41M | ﹤0.01% | 3944 |
|
|
2018
Q2 | $632K | Buy |
+20,400
| New | +$477K | ﹤0.01% | 5992 |
|
|
2015
Q3 | – | Sell |
-2,300
| Closed | -$22K | – | 9217 |
|
|
2015
Q2 | $22K | Buy |
+2,300
| New | +$21.3K | ﹤0.01% | 8107 |
|
|
2015
Q1 | – | Sell |
-1,100
| Closed | -$10K | – | 8831 |
|
|
2014
Q4 | $10K | Sell |
1,100
-500
| -31% | -$4.84K | ﹤0.01% | 8138 |
|
|
2014
Q3 | $17K | Sell |
1,600
-6,400
| -80% | -$76.1K | ﹤0.01% | 7562 |
|
|
2014
Q2 | $134K | Buy |
8,000
+7,500
| +1,500% | +$123K | ﹤0.01% | 5969 |
|
|
2014
Q1 | $9K | Buy |
+500
| New | +$8.05K | ﹤0.01% | 7545 |
|
Other funds holding STAA
BC
YC
MAP
VPM
VCM
AIM
Citadel Advisors's STAA Position: Q1 2026 in Review
Citadel Advisors increased its STAAR Surgical (STAA) stake by 416% in Q1 2026, buying an estimated $16.3M and bringing the position to 1,059,428 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2354.
Citadel Advisors first reported a position in STAA in Q4 2013 and has held it in 39 quarters since. The position peaked at $38M in Q3 2023. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.
- Citadel Advisors held 1,059,428 shares of STAAR Surgical worth $19.8M as of Q1 2026.
- Citadel Advisors bought 854,309 STAAR Surgical shares in Q1 2026, an estimated $16.3M.
- STAAR Surgical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2354 holding.
- Citadel Advisors first reported a position in STAAR Surgical in Q4 2013 and has held it in 39 quarters since.
- Citadel Advisors's STAAR Surgical position peaked at $38M in Q3 2023.
- 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.